XML 10 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 3 - Reverse Merger (Details) (USD $)
12 Months Ended 42 Months Ended 0 Months Ended
Dec. 31, 2013
Dec. 31, 2013
Aug. 25, 2013
Aug. 24, 2013
Dec. 31, 2013
In Process Research and Development Acquired [Member]
Aug. 25, 2013
Immune Ltd. [Member]
Aug. 25, 2013
AmiKet [Member]
Note 3 - Reverse Merger (Details) [Line Items]              
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares           10,490,090  
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners     19.00% 19.00%      
Business Acquisition, Percentage of Voting Interests Acquired     81.00% 81.00%      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill $ 27,500,000 $ 27,500,000 $ 27,500,000        
Business Combination, Overall Fair value of Projects Assumed, Before Valuation Method Discount             91,700,000
Income Approach Discount Rate, Percentage     30.00%        
Fair Value of Assumed Projects after Discounted Income Approach, Percentage of Fair Value Retained     30.00%        
Deferred Tax Liabilities, Net, Noncurrent 10,870,063 10,870,063     10,900,000    
Business Combination, Bargain Purchase, Gain Recognized, Amount $ 6,444,000 $ 6,444,000